KLP Kapitalforvaltning AS bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 119,562 shares of the medical equipment provider’s stock, valued at approximately $62,407,000.
Other hedge funds have also added to or reduced their stakes in the company. Bennett Selby Investments LP boosted its holdings in Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after acquiring an additional 17 shares during the last quarter. Onefund LLC boosted its holdings in shares of Intuitive Surgical by 1.9% in the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after buying an additional 18 shares during the last quarter. LVW Advisors LLC boosted its holdings in shares of Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after buying an additional 19 shares during the last quarter. Wesbanco Bank Inc. boosted its holdings in shares of Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after buying an additional 19 shares during the last quarter. Finally, Journey Strategic Wealth LLC boosted its holdings in shares of Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after buying an additional 19 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of brokerages recently weighed in on ISRG. Raymond James boosted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Evercore ISI upped their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Leerink Partners upped their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a report on Tuesday. Finally, Barclays upped their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $611.86.
Insiders Place Their Bets
In other news, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 over the last quarter. 0.90% of the stock is owned by corporate insiders.
Intuitive Surgical Price Performance
Shares of ISRG opened at $492.49 on Friday. The firm has a market cap of $175.41 billion, a P/E ratio of 76.83, a P/E/G ratio of 5.85 and a beta of 1.43. The stock has a 50 day simple moving average of $562.24 and a two-hundred day simple moving average of $531.34. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- How to buy stock: A step-by-step guide for beginnersÂ
- MarketBeat Week in Review – 03/17 – 03/21
- What is the S&P/TSX Index?
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Stock Analyst Ratings and Canadian Analyst Ratings
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.